"First, Do No Harm"-Trainees' Observation of Risk Reduction in the Treatment of Overactive Bladder. 

 -  2021 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>2151-8378 
<br/><br/><label>Standard No.: </label>01436319-202101000-00002 [pii] 10.1097/SPV.0000000000000978 [doi] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Cholinergic Antagonists/ae [Adverse Effects]<br/>*Dementia/ci [Chemically Induced]<br/>*Urinary Bladder, Overactive/dt [Drug Therapy]<br/>Acetanilides/tu [Therapeutic Use]<br/>Aged<br/>Dementia/ep [Epidemiology]<br/>Dementia/pc [Prevention & Control]<br/>Female<br/>Humans<br/>Insurance Coverage<br/>Middle Aged<br/>Risk<br/>Thiazoles/tu [Therapeutic Use]<br/>Urological Agents/tu [Therapeutic Use]
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Washington Hospital Center
<br/><br/><label>Index Terms--Occupation: </label><br/>Obstetrics and Gynecology/Female Pelvic Medicine and Reconstructive Surgery
<br/><br/><label>Index Terms--Function: </label><br/>Journal Article